(Press-News.org) The international NOvA collaboration presented new results at the Neutrino 2024 conference in Milan, Italy, on June 17. The collaboration doubled their neutrino data since their previous release four years ago, including adding a new low-energy sample of electron neutrinos. The new results are consistent with previous NOvA results, but with improved precision. The data favor the “normal” ordering of neutrino masses more strongly than before, but ambiguity remains around the neutrino’s oscillation properties.
The latest NOvA data provide a very precise measurement of the bigger splitting between the squared neutrino masses and slightly favor the normal mass ordering. That precision on the mass splitting means that, when coupled with data from other experiments performed at nuclear reactors, the data favor the normal ordering at almost 7:1 odds. This suggests that neutrinos adhere to the normal ordering, but physicists have not met the high threshold of certainty required to declare a discovery.
NOvA, short for NuMI Off-axis νe Appearance, is an experiment managed by the U.S. Department of Energy’s Fermi National Accelerator Laboratory, located outside of Chicago. Fermilab sends a beam of neutrinos 500 miles north to a 14,000-ton detector in Ash River, Minnesota. By measuring the neutrinos and their antimatter partners, antineutrinos, in both locations, physicists can study how these particles change their type as they travel, a phenomenon known as neutrino oscillation.
NOvA aims to learn more about the ordering of neutrino masses. Physicists know that there are three types of neutrinos with different masses, but they don’t know the absolute mass, nor which is heaviest. Theoretical models predict two possible mass orderings, normal or inverted. In the normal ordering, there are two light neutrinos and one heavier neutrino; in inverted, there is one light neutrino and two heavier ones.
“Getting additional information from reactor experiments enhances our knowledge of the mass ordering and gets us close to exciting territory,” said Erika Catano-Mur, a postdoctoral research associate at William & Mary and co-convener of the analysis. “We almost have an answer to one of those big questions that we have in neutrino physics. But we’re not there yet.”
The solution to neutrino oscillation remains ambiguous in the new results. Physicists don’t currently have enough data to disentangle two effects on the oscillation: mass ordering and a property called Charge Parity violation. The collaboration observed a moderate amount of oscillation that could be explained in either mass ordering scenario with different amounts of CP violation, so they cannot tease apart the mass ordering and CP violation. However, the physicists were able to rule out specific combinations of the two properties.
“It really takes more than one measurement for us to learn everything we need to know,” said Jeremy Wolcott, a postdoctoral fellow at Tufts University, one of NOvA’s analysis coordinators and the speaker at the conference.
“NOvA is an important player in this because there are unique aspects to all of the various experiments that are trying to measure the same parameters,” said Wolcott. “We’re starting to see a picture come together, but it’s murky. Having different measurements that all work together is really important.”
The NOvA experiment started taking data in 2014 and will continue running through early 2027, during which time the collaboration hopes to double their antineutrino dataset. They also continue to implement analysis improvements to maximize the sensitivity of the experiment.
Their efforts are also paving the way for future experiments that will seek to contribute even more to solving the mysteries around neutrino properties.
“We want to make the most that we can out of the data,” said Catano-Mur. “What we learn — not only from the results themselves, but in the process, what we’re learning about the analysis methods — is going to be useful for the next generation of experiments that right now are under construction.
Still, NOvA has the potential to reveal more about the elusive neutrino. “This result is an important reminder that the current generation of experiments, including NOvA, continues to collect valuable data and produce physics insights,” said Zoya Vallari, postdoctoral researcher at CalTech and co-convener of the analysis. “They are our best shot at a discovery right now.”
The NOvA collaboration is made up of more than 200 scientists from 50 institutions in eight countries. With the additional data and further analysis improvements, NOvA will bring physicists closer to understanding the identity-changing behavior of neutrinos.
Fermi National Accelerator Laboratory is supported by the Office of Science of the U.S. Department of Energy. The Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit science.energy.gov
END
New NOvA results add to mystery of neutrinos
2024-06-18
ELSE PRESS RELEASES FROM THIS DATE:
Gastroenterologists generally trust and accept use of AI medical tools in clinics and hospitals, finds NTU Singapore study
2024-06-18
Artificial intelligence (AI) has permeated many aspects of medicine, with promises of accurate diagnoses, better management decisions, and improved outcomes for both patients and the healthcare system. However, to successfully implement AI technology in clinical practice, trust and acceptance among healthcare providers to use such tools is crucial.
Now, using the treatment of digestive diseases as a case study, an international study led by Nanyang Technological University, Singapore (NTU Singapore) has found that doctors in the gastroenterology practice generally trust and accept AI medical tools.
Through ...
State cannabis legalization and trends in cannabis-related disorders in older adults
2024-06-18
About The Study: Rates of cannabis-related disorder encounters increased from 2017 through 2022 among Medicare-insured older adults. This study observed the highest rates in states or territories that legalized adult and medical use of cannabis. The results also suggest higher average annual increases in states or territories that legalized medical cannabis.
Corresponding author: To contact the corresponding author, Silvia Perez-Vilar, Ph.D., Pharm.D., email silvia.perezvilar@fda.hhs.gov
To access the embargoed study: Visit our For The Media ...
Availability of medications for opioid use disorder in community mental health facilities
2024-06-18
About The Study: In this study of 450 community outpatient mental health treatment facilities in 20 high-burden states, approximately one-third offered medications for opioid use disorder (MOUD). These results suggest that further study is needed to report MOUD uptake, either through increased prescribing at all clinics or through effective referral models.
Corresponding author: To contact the corresponding author, Jonathan Cantor, Ph.D., email jcantor@rand.org.
To access the embargoed study: Visit our For The Media website at this link ...
Variation in postoperative outcomes across federally designated hospital star ratings
2024-06-18
About The Study: Although Centers for Medicare & Medicaid Services (CMS) hospital star rating was associated with postoperative mortality, serious complications, and readmissions, there was wide variation in surgical outcomes within each star rating group. These findings highlight the limitations of the CMS hospital star rating system as a measure of surgical quality and should be a call for continued improvement of publicly reported hospital grade measures.
Corresponding Author: To contact the corresponding author, Adrian Diaz, M.D., M.P.H., email adrian.diaz@osumc.edu.
To access the embargoed ...
Sepsis patients could get the right treatment faster, based on their genes
2024-06-18
Sepsis patients could be treated based on their immune system’s response to infection, not their symptoms.
New research uncovers how different people respond to sepsis based on their genetic makeup, which could help identify who would benefit from certain treatments and lead to the development of targeted therapies.
The team, from the Wellcome Sanger Institute, the University of Oxford, and collaborators, built on their previous work that identified different subgroups of patients with sepsis. They aimed to understand more about why sepsis response varies between patients and the different underlying immune response pathways.
The new study, published today (18 June) in Cell Genomics, ...
Odors are encoded in rings in the brain of migratory locusts
2024-06-18
The migratory locust Locusta migratoria is an economically important crop pest that is said to have come to Egypt in the Old Testament as the eighth of the ten biblical plagues, "to devour all that plants that grow". The migratory locust is rarely found in Europe, but in Africa and Asia it not only causes millions of dollars’ worth of damage but also has a deadly impact on local people, threatening their food and their very existence. The locusts occur in two phases: as solitary animals and in swarms. The insects are most feared when they ...
New global research aims to improve survival rates for pancreatic cancer patients
2024-06-18
A new study published today in JAMA Network Open by an international cohort of researchers provides the latest data on the effectiveness of treating pancreatic cancer patients with chemotherapy (with or without radiation therapy) before surgery to remove a tumor. The study focuses specifically on pancreatic adenocarcinoma patients.
The research found that after treatment and surgery, nearly five percent of patients had no detectable cancer cells left in the area where the tumor was, achieving a pathological complete response (pCR).
“PCR means that the cancer has responded extremely well to the treatment, leaving no ...
Medication treatment for opioid use disorder offered at only a third of outpatient mental health facilities
2024-06-18
Only a third of outpatient community mental health treatment facilities in 20 states with the highest opioid related overdose deaths report offering medication treatment for opioid use disorders, suggesting efforts may be needed to strengthen such services, according to a new RAND study.
Among the 450 clinics surveyed, factors that increased the likelihood that clinics would provide medication for opioid use disorders included being a certified behavioral health clinic and providing integrated mental and substance use disorder treatment.
Researchers found that most clinics that did not offer medication treatment said they referred patients to other clinics for ...
Salk scientist Jesse Dixon named 2024 Pew Biomedical Scholar
2024-06-18
LA JOLLA (June 18, 2024)—Salk Institute Assistant Professor Jesse Dixon has been named a 2024 Pew Biomedical Scholar by The Pew Charitable Trusts. This honor provides funding to early-career investigators who demonstrate outstanding promise in science toward advancing human health. Dixon and the other 21 awardees will each receive $300,000 over four years to support their research.
“Through his development and use of leading-edge genetic tools, Jesse has already made a major impact on how we study diseases such ...
Pew supports 22 researchers leading scientific innovation
2024-06-18
PHILADELPHIA—The Pew Charitable Trusts today announced the 22 researchers who have been selected to join the Pew Scholars Program in the Biomedical Sciences. These early-career scientists will receive four years of funding to explore some of the most pressing questions in human health and medicine.
“Pew believes that supporting promising early-career researchers is key to scientific innovation, and for nearly 40 years our scholars have helped change the world—creating lifesaving therapies and responding to emerging health crises around the globe,” ...